Published September 25, 2018 -- Antimicrobial resistant pathogens pose an ongoing and increasing challenge to hospitals since they cause healthcare-associated infections (HAIs) during clinical treatment of patients. In addition, these pathogens pose a difficult challenge in the prevention of cross-transmission and contamination. Existing methods to address this challenge have included aggressive sanitizers or “bleach” treatment and deployment of UV-C technology. UV-C refers to ultraviolet light with wavelengths between 200 – 280 nanometers. Both solutions have limitations. The effectiveness of sanitizer treatments is limited to the thoroughness of application process, often limited by time constraints between patient room turnover and the effectiveness of the cleaning staff. The effectiveness of UV-C technology is limited to line-of-sight and physical distance from the device, as well as by steady degradation of treatment efficacy with bulb life. In each case, the solution is a onetime treatment without continuous cleaning or ongoing prophylaxis, and neither solution addresses airborne pathogens.